Here are four points:
1. The device is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2 to S1.
2. The device, developed Camber Spine Technologies, is designed to be used with additional FDA-cleared supplementary fixation systems.
3. Dr. Gleimer implanted the device in a two-level lumbar procedure at levels L4/L5 and L5/S1 at Kennedy University Hospital-Washington Township in Turnersville, N.J.
4. Dr. Gleimer practices with Cherry Hill, N.J.-based Regional Orthopedic Professional Association. He completed spine surgery fellowship training at the Southern California Orthopedic Institute in Van Nuys, Calif.
More articles on devices:
Zimmer Biomet celebrates 40 years of Oxford Partial Knee System use: 4 key takeaways
OrthoPediatrics releases PediLoc Infant LPF Plating System: 4 things to know
Global sports medicine devices market to reach $8.63B by 2020: 3 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
